Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial

Authors: Aung Naing, Deborah J. Wong, Jeffrey R. Infante, W. Michael Korn, Raid Aljumaily, Kyriakos P. Papadopoulos, Karen A. Autio, Shubham Pant, Todd M. Bauer, Alexandra Drakaki, Naval Daver, Annie Hung, Navneet Ratti, Scott McCauley, Peter Van Vlasselaer, Rakesh Verma, David Ferry, Martin Oft, Adi Diab, Edward B. Garon, Nizar M. Tannir - The Lancet 2019 cited by 119